Ocular toxoplasmosis during natalizumab treatment

Neurology. 2009 Oct 27;73(17):1418-9. doi: 10.1212/WNL.0b013e3181bd114f. Epub 2009 Sep 23.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Eye / pathology
  • Humans
  • Immune Tolerance*
  • Immunocompromised Host*
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Natalizumab
  • Ophthalmoscopy
  • Toxoplasma*
  • Toxoplasmosis, Ocular / diagnosis
  • Toxoplasmosis, Ocular / etiology*
  • Toxoplasmosis, Ocular / pathology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab